Jubilant Therapeutics Inc. Appoints Daniel J. O’Connor as President and Chief Executive Officer
Jubilant Therapeutics Inc. appoints Daniel J. O'Connor as President & Chief Executive Officer, effective December 1, ...
Read moreDetails
Tag: small molecule therapeutics
"HR Today" aspires to be more than just a publication; it aims to be a platform where the brightest minds in HR come together to share knowledge, insights, and foresight that can shape the future of our profession. We aim to offer a unique blend of academic rigour and practical wisdom, addressing the most pressing challenges and opportunities in the HR landscape today.